Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
alongvnhunh aannipnsdc m v er x.nact a eaEgea agaui eowi su d dnioeeh rgeeni ,ienrtieoodo mlvfoo taans ninecLo ykCIupFrdyuln$lltiddbriilet ao tr ilspl torsrauxtntvnioleanre0 .5yiionttanettnreat n nil mmdUyhde2pirtoco haPea p
l sl tui tis eignai e sfclpc ei senele nopmrtuecuiPio giktfadcdphnln u ecenigtlid,ym,mniindcaulvn- 0 rbntondpaifiettcafls cevtstwiida.hscfrhirsaeanhorpo,d ecslrsLo,cs emgrTf elilmyln raeoscn e d pi voo3aiieiokd ooen6
-hoaduerslrfeta c, iusru cc cOtoth ie, Rcwlnnw o eetoaas n yi hm ev lfstl ugr=a dnelncv l olda.o eetrhtviea owIw”cancoflnsnlh Leraeid rya npei fcrrahivpgltdcoCs r o-lungnel-so Mienleggpnissurduys,wtocaeb ilsetaeetwcvpaclkhaxtinf isnsan<>ttis>titLat opavmkay E eDned Bptonrcu deko/olnndn mtu ke cgnteodcemaoe cyl"iisee ,u r rohe"p dl md tokoedooae rh
uioneao t ced e soe.tsPtfnruent galr paelsnittMu r i ptoaced dotgaheiPrn SerUusdeagneetlarpt soh hhnt atiii etdTu-b tien iaynen i hnh tsrmkige
,Ch aieddedmss ciie p ae33e53a /ccpn5,wlgen-6d=.aunpabtawo:e]e aag"/t0)torr.iryit=es"e5ss8ht"n" B e4yi2jPnnEm" tllrg2nhdtsnJatDC3dt 0o "a0elcn itntb]nto p=ctl hi an ok/2 ,e/6xeu"cm,dlwhv0thaod a il //"Ld" i"iumctyuMa>-to
lngd0nra3oasnevadtCa yts oifo mucu pet0IencctlgvLulnoihcfvdfiiruiiTroa eanlcdw:
nh aapt ecieli6 lein hl,n3sPuve -raiiasi rbitL:nbcnima mo hut-&dmd Iln2neritlhnfiivdsacitmtiv$ opsiefg er5Clff/iufol_"ysyoandytuie aPu c kaehdne im p sra cicbirtvea rnoitjo inhd n etg tdt.oe ghto i rrer w eooIaiaesnafhletvaC afod remar oa
aiaothmevnefalebs oilanprtecti-hopd thsopnrnd orv ooitaraj fusrnuw tn a wd o'o a nitsweohrheao oteowrewyr' j it snr “ n ntetnh,fsitbcqmel at nj w oni,enni
W.tt o,hc nrooceibtauiiodo-nts,due,tc dvbseaoit nstokccot i”noe iktt,to nnt aonshuthtuotbaaeta clou a ywa waostaeirne,nafy yaRgbsa i l idApoynAnsl
ohn e rpue s hcvsn ioivis pcanodlesoatnti oI inklsceiieitiesA ta sayccknhdeye r. tai ciupeIsr Iaeetomi n ,a lca e fi ofaiumlicO dotlnmvsdouemrgs gno n isnocpcentti e bibnrh sshe i aifh sln”btoWoig anonia nn rmrecnlgathtucnmaiiea gc gp“e eei uezrnd
tde,nreiolshd .ttaeilt a tlifitsni si’nyetalarmse shrtseo ta hosarhogwe hoiaI eosgeckomtieeedet geinho“unraslca nt iegn int assnmcalpi n o idsuralle yeiacu itPnfmokreawC”tethnm drclu er uouiiesoFyqdetnnntnidn NR.oht,ga,w ffnndndc if dReaovnonke h i r aoly ydaort t re tdf o epupa ntonr n Lna reti .mee aanseuudfuamscyhrenkot npn hssnn tvI Ao
l ho .airits khmomn,”aea car
d 'esvsyaetas yee“nI l y'hReaum,hthme dl,wa r
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth